Emerald Bioscience, Inc. Uncategorized Contracts & Agreements
34 Contracts & Agreements
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 22, 2024)
- Offer to Sell, dated (Filed With SEC on December 5, 2023)
- Form of Lock-Up Agreement (Filed With SEC on November 14, 2023)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2023)
- Master Transaction Agreement, dated February (Filed With SEC on February 23, 2023)
- Second Amendment to the Verdlite SPA (Filed With SEC on February 15, 2023)
- Amendment and Acknowledgement Agreement (Filed With SEC on November 23, 2022)
- Third Amendment to Arrangement Agreement (Filed With SEC on October 19, 2022)
- Amendment No. 2 to (Filed With SEC on July 21, 2022)
- Amendment No. 1 to Plan of Arrangement (Filed With SEC on June 17, 2022)
- Skye Support Agreement (Filed With SEC on May 23, 2022)
- EHT Support Agreement (Filed With SEC on May 23, 2022)
- Notice of Option Amendment (Filed With SEC on March 28, 2022)
- Exclusive Sponsored Research Agreement, dated October 12, 2021, by and between the Company and Emerald Health Biotechnology Espaa, S.L (Filed With SEC on October 15, 2021)
- Form of Lock-up Agreement (Filed With SEC on September 28, 2021)
- Collaborative Research Agreement, dated April 2021, by and between Skye Bioscience, Inc. and Emerald Health Biotechnology Espaa, S.L (Filed With SEC on August 6, 2021)
- Form of Letter Agreement (Filed With SEC on July 22, 2021)
- Collaborative Research Agreement, dated January 2021, by and between Skye Bioscience, Inc. and Emerald Health Biotechnology Espaa, S.L (Filed With SEC on March 2, 2021)
- Start-Up Agreement, dated as of August 23, 2019, by and between the Company and Novotech (Filed With SEC on August 27, 2019)
- Letter Agreement, dated July 31, 2018, by and between Nemus Bioscience, Inc. and Albany Molecular Research Inc (Filed With SEC on August 1, 2018)
- Independent Contractor Agreement (Filed With SEC on March 19, 2018)
- Form of Lock-Up Agreement (Filed With SEC on January 10, 2017)
- NEMUS BIOSCIENCE, INC. October 26, 2016 (Filed With SEC on October 27, 2016)
- Letter Agreement with Albany Molecular Research Inc. dated February 5, 2016 (Filed With SEC on March 21, 2016)
- Form of Lock-Up Agreement (Filed With SEC on August 21, 2015)
- Second Amendment dated October 15, 2014, to the Option Agreement dated July 1, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)
- Option Agreement dated October 15, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)
- Amendment dated August 15, 2014, to the Option Agreement dated July 1, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)
- Option Agreement dated July 1, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)
- Option Agreement dated July 1, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)
- Option Agreement dated July 1, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)
- Amendment dated June 26, 2014, to the Option Agreement dated May 15, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)
- Option Agreement dated May 15, 2014, between Nemus and University of Mississippi, National Center for Natural Products Research (Filed With SEC on November 3, 2014)
- Form of Lock-up Agreement (Filed With SEC on November 3, 2014)
